country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa

Med Ann Dist Columbia. 1974 Dec;43(12):587-91.

J Fermaglich

PMID: 4532167

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-B0311

Carbidopa

99.84%, Decarboxylase Inhibitor

target: Aryl Hydrocarbon Receptor

Research Areas: Neurological Disease; Cancer
HY-B0311A

Carbidopa monohydrate

99.84%, Aryl Hydrocarbon Receptor Modulator

target: Aryl Hydrocarbon Receptor

Research Areas: Neurological Disease; Cancer
HY-B0311AS

Carbidopa-d₃ monohydrate

98.53%, Stable Isotope

target: Aryl Hydrocarbon Receptor

Research Areas: Neurological Disease; Cancer
HY-B0311S1

Carbidopa-d₃-1

Stable Isotope

target: Aryl Hydrocarbon Receptor; Isotope-Labeled Compounds

Research Areas: Neurological Disease
HY-B0311D

Carbidopa hydrochloride

Decarboxylase Inhibitor

target: Aryl Hydrocarbon Receptor

Research Areas: Cancer
HY-B0311AR

Carbidopa monohydrate (Standard)

Aryl Hydrocarbon Receptor Modulator

target: Reference Standards; Aryl Hydrocarbon Receptor

Research Areas: Neurological Disease; Cancer
HY-B0311R

Carbidopa (Standard)

Decarboxylase Inhibitor

target: Aryl Hydrocarbon Receptor; Reference Standards

Research Areas: Neurological Disease; Cancer